Akrotome Imaging, Inc. specializes in advanced imaging technologies that enhance the visualization of biological samples. Their primary focus is on high-resolution imaging techniques that allow for detailed analysis of cellular structures and functions. The company employs cutting-edge methods such as optical sectioning and multi-dimensional imaging, which enable researchers to capture intricate details of samples in three dimensions. This technology is particularly beneficial in fields like biomedical research, where understanding the microanatomy of tissues is crucial for advancing diagnostics and therapeutic strategies.

In addition to imaging, Akrotome Imaging, Inc. integrates sophisticated software solutions that facilitate data analysis and interpretation. Their platforms are designed to handle large datasets generated from imaging processes, providing tools for quantitative analysis and visualization. This combination of advanced imaging hardware and robust software capabilities positions Akrotome Imaging as a leader in the field, supporting researchers in their quest to uncover new insights in cellular biology and related disciplines.

United States

Akrotome Imaging, Inc. is focused on the clinical translation of cancer-targeted molecular probes into enhanced approaches for surgery and diagnostics, leading to improved outcomes and patient quality of life while positively impacting healthcare economics. 

Akrotome is a Delaware C Corporation with offices in Ohio, Indiana, and California. The company was first incorporated in 2008 and the current management team has been in place since May of 2012. The company's approach stresses the efficient use of capital, coupled with strategies that emphasize the fastest routes to the clinical market with the lowest regulatory overhead.

11000 Cedar Avenue, Cleveland, Ohio 44106-5056, US

Akrotome Imaging, Inc.

Company Details